Liranaftate is a topical antifungal agent used as an active pharmaceutical ingredient (API). It works by inhibiting fungal cell membrane synthesis, leading to growth suppression and cell death. Liranaftate is effective against dermatophytes and is commonly used to treat superficial fungal infections including tinea pedis (athlete’s foot), tinea corporis, and tinea cruris. Its therapeutic use is listed as antifungals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zefnart and Liranaftato. Its PubChem CID is 3936.
Liranaftate
| CAS No | 88678-31-3 |
|---|---|
| Molecular Formula | C18H20N2O2S |
| Molecular Weight | 328.40 g/mol |
| Synonyms | O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxy-2-pyridinyl)-N-methylcarbamothioate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Liranaftate is a topical antifungal agent used as an active pharmaceutical ingredient (API). It works by inhibiting fungal cell membrane synthesis, leading to growth suppression and cell death.
The listed CAS number is 88678-31-3.
The listed molecular formula is C18H20N2O2S.
The listed molecular weight is 328.40 g/mol.
O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxy-2-pyridinyl)-N-methylcarbamothioate.
The source lists Zefnart and Liranaftato.